Condition

Gastrointestinal Stromal Tumors (GIST) (2)

Other Relapsed or Refractory Solid Tumors (1)

Overall Status

Completed (2)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Blueprint Medicines Corporation (1)

Novartis Pharmaceuticals (1)

Collaborator

Intervention

amn107- nilotinib (1)

avapritinib (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

gastrointestinal stromal tumors (gist)

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Gastrointestinal Stromal Tumors (GIST), Other Relapsed or Refractory Solid Tumors Trial in Worldwide (Avapritinib)

Completed

Gastrointestinal Stromal Tumors (GIST)
Other Relapsed or Refractory Solid Tumors

Avapritinib

Scottsdale, Arizona
+18 more

May 20, 2022

Gastrointestinal Stromal Tumors (GIST) Trial in Jerusalem, Tel Aviv, Tel Hashomer (AMN107- NILOTINIB)

Completed

Gastrointestinal Stromal Tumors (GIST)

AMN107- NILOTINIB

Jerusalem, Israel
+2 more

Jun 21, 2017